ORIGINAL RESEARCH article
Front. Neurol.
Sec. Headache and Neurogenic Pain
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1577399
Safety and efficacy of percutaneous radiofrequency thermocoagulation with varying puncture trajectories for recurrent maxillary trigeminal neuralgia: a prospective study
Provisionally accepted
- Second Hospital of Hebei Medical University, Shijiazhuang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Recurrence of maxillary trigeminal neuralgia (TN) poses a significant clinical challenge. Percutaneous radiofrequency thermocoagulation (PRT) has been established as an effective treatment for maxillary TN. However, the safety and efficacy of different puncture pathways, particularly in the context of pain recurrence, may vary. Objective: This study aimed to compare the safety and efficacy of PRT via the foramen ovale (FO) and pterygopalatine fossa (PF) approaches for recurrent maxillary TN. Methods: This prospective, non-randomized controlled study included 46 patients with recurrent maxillary TN who underwent PRT at our hospital between January 2021 and June 2021. Patients were divided into two groups based on the puncture pathway: the FO group and the PF group. All procedures were performed under local anesthesia and guided by computed tomography (CT). Operative complications were monitored, and pain was assessed using the Visual Analog Scale (VAS) and the Barrow Neurological Institute (BNI) scale. Follow-up evaluations were conducted at 6, 12, 18, and 24 months postoperatively. Results: The efficacy rates of the two puncture pathways within 24 months were 69.5% (FO group) and 78.2% (PF group), respectively. All patients experienced hypoesthesia in the maxillary nerve area. No severe complications, such as blindness, intracranial hemorrhage, or intracranial infection, were observed in either group. Conclusion: Both the FO and PF puncture pathways for PRT are safe and effective for treating recurrent maxillary TN. However, for patients with a history of prior PRT or percutaneous balloon compression (PBC) targeting the Gasserian ganglion, the PF approach may be preferable.
Keywords: Trigeminal Neuralgia, Maxillary Nerve, Foramen Ovale, Pterygopalatine Fossa, recurrent, Percutaneous radiofrequency thermocoagulation
Received: 15 Feb 2025; Accepted: 16 Jun 2025.
Copyright: © 2025 Du, Liu, Shi, Liu, Ren and Xi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lulu Xi, Second Hospital of Hebei Medical University, Shijiazhuang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.